Tamoxifen Can Help Stave Off Breast Cancer

Pharmacy Times
Volume 0

Women at high risk for developingbreast cancer who take tamoxifencan reduce their long-term risk ofdeveloping the disease, according tothe results of a recent study.Researchers found that women whotook the drug for up to 5 years were~43% less likely to get breast cancerthan those who took a placebo.

The study, which was funded bythe National Cancer Institute, involved13,388 women. The womeneither were aged >60 years or werebetween the ages of 35 and 59 yearsand at high risk (ie, having an immediaterelative with breast cancer). Theywere divided into 2 groups. Of thewomen who took tamoxifen, only 145developed breast cancer since thestart of the study, compared with 250women in the placebo group.

Although a number of medicinesexist that help to fight breast canceronce it has developed, only tamoxifenhas US approval to help prevent it inhigh-risk women. The data alsoshowed that women taking the drugexperienced fewer broken bonesthan those taking the placebo—80women compared with 116, respectively(Journal of the National CancerInstitute, November 15, 2005).

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.